• Home
  • Meetings
  • Online Activities
  • Patient Educcation
  • Resources
  • Industry Information
Skip Navigation Links.
Activity Information
Presentation
Differential Diagnosis
Initial Labs & Tests
Results
Diagnosis
Initial Treatment
Clinical Course
Table 3
Next Step
Adverse Events
Treatment Options
Follow-Up
Summary
Nesiritide for CHF
References
Finish

Online CME Activity

NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
Managing a Patient with Acute Decompensated Heart Failure
Expiration Date:
03/31/2006
Topics:
Cardiology, Heart Failure, Respiratory
Primary Audience:
Primary Care
Activity Format:
Patient Case Study
Credits:
2.00 AMA PRA Category 1 Credits™

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Full Star 100%

Learning Objective

List three factors to consider in the differential diagnosis of acute decompensated heart failure and discuss at least three pharmacologic and nonpharmacologic treatment options.

Accreditation

This educational program is conceived and credited in accordance with ACCME’s Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute’s Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
2.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Faculty and Editorial Board

Written By: Monica Zangwill, MD, MPH, (Read Bio), Clinical Editor, Pri-Med Institute, Boston, MA;

Reviewed By: Paul Hauptman, MD, Professor of Medicine, St. Louis University School of Medicine, St. Louis, MO;

Edited By: Jean Baker, MS, RD, Clinical Editor, Pri-Med Institute, Boston, MA;

Financial Disclosure Statement(s)

Dr. Hauptman has received honoraria and is on the speakers bureau for GlaxoSmithKline.
Dr. Zangwill has no significant relationships to disclose.
Ms. Baker has no significant relationships to disclose.

Education Partner:

Pri-Med Institute

Commercial Support:

N/A

Pri-Med Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.